C2 and leukemia: Among children with leukemia undergoing haploidentical transplants, donor-derived KIR2DL2/3+ NK cells showed reduced alloreactivity against HLA-C2 leukemia cells, while KIR2DL1+ NK cells had robust killing against HLA-C1 leukemia cells [33].